These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 21762992

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The systemic safety of bromfenac ophthalmic solution 0.09%.
    Stewart RH, Grillone LR, Shiffman ML, Donnenfeld ED, Gow JA, Bromfenac Ophthalmic Solution 0.09% Study Group.
    J Ocul Pharmacol Ther; 2007 Dec; 23(6):601-12. PubMed ID: 18001250
    [Abstract] [Full Text] [Related]

  • 6. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
    Miyanaga M, Miyai T, Nejima R, Maruyama Y, Miyata K, Kato S.
    Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412
    [Abstract] [Full Text] [Related]

  • 7. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.
    Tan DT, Chee SP, Lim L, Lim AS.
    Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation.
    Paganelli F, Cardillo JA, Melo LA, Oliveira AG, Skaf M, Costa RA, Brazilian Ocular Pharmacology and Pharmaceutical Technology Research Group.
    Ophthalmology; 2004 Nov; 111(11):2102-8. PubMed ID: 15522378
    [Abstract] [Full Text] [Related]

  • 15. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
    Coassin M, Iovieno A, Soldani A, Cavuto S, Cimino L, Sartori A, Formisano D, Fontana L.
    J Cataract Refract Surg; 2016 Aug; 42(8):1119-25. PubMed ID: 27531286
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The efficacy of bromfenac ophthalmic solution 0.07% dosed once daily in achieving zero-to-trace anterior chamber cell severity following cataract surgery.
    Silverstein SM, Jackson MA, Goldberg DF, Muñoz M.
    Clin Ophthalmol; 2014 Aug; 8():965-72. PubMed ID: 24876763
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.